Published in Curr Pharm Des on January 01, 2004
A Computational Model for Predicting RNase H Domain of Retrovirus. PLoS One (2016) 1.39
Clinical significance of human immunodeficiency virus type 1 replication fitness. Clin Microbiol Rev (2007) 1.31
Antiretroviral therapy in macrophages: implication for HIV eradication. Antivir Chem Chemother (2009) 1.27
Development of a human immunodeficiency virus vector-based, single-cycle assay for evaluation of anti-integrase compounds. Antimicrob Agents Chemother (2006) 0.94
Inhibiting the HIV integration process: past, present, and the future. J Med Chem (2013) 0.93
Use of new T-cell-based cell lines expressing two luciferase reporters for accurately evaluating susceptibility to anti-human immunodeficiency virus type 1 drugs. J Clin Microbiol (2006) 0.90
Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy. Cell Biosci (2012) 0.81
Virtual screening models for prediction of HIV-1 RT associated RNase H inhibition. PLoS One (2013) 0.80
Alpha-1-antitrypsin interacts with gp41 to block HIV-1 entry into CD4+ T lymphocytes. BMC Microbiol (2016) 0.75
Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses. AIDS Res Hum Retroviruses (2015) 0.75
Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs. Bioorg Med Chem (2014) 0.75
Venom Components of Iranian Scorpion Hemiscorpius lepturus Inhibit the Growth and Replication of Human Immunodeficiency Virus 1 (HIV-1). Iran Biomed J (2016) 0.75